Presentation NY Valves 2025 Impact of Sodium Glucose Co-Transporter 2 Inhibitors on Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve Implantation: A Systematic Review and Meta-Analysis Presenter: Ogechukwu Samuel Obi June 26, 2025
Presentation NY Valves 2025 Death on Waiting List for Transcatheter Aortic Valve Implantation: Current Incidence, Clinical Characteristics and Predictive Factors Presenter: Hugo Poinsignon June 25, 2025
Presentation NY Valves 2025 Rare Case of Acute Severe Mitral Regurgitation Following Transcatheter Aortic Valve Implantation (TAVI) Presenter: Ho On Alston Conrad Chiu June 25, 2025
Presentation NY Valves 2025 Successful Acute Valve-in-Valve Implantation Using Evolut FX Transcatheter Valve in a Failed Non-Calcified Stentless Subcoronary Toronto (SJM) Valve With Severe Aortic Regurgitation Presenter: Virna Liza Sales June 25, 2025
News Conference News EuroPCR 2025 Myval Noninferior to Other THVs at 1 Year, but Questions Persist L.A. McKeown May 21, 2025
News Daily News COMPARE-TAVI 1: Myval Performs Well Against Sapien at 1 Year Todd Neale April 11, 2025
News Conference News EHRA 2025 Post-TAVI Pacemaker Tied to Poorer Long-term Outcomes Todd Neale April 08, 2025
News Conference News ACC 2025 Dapagliflozin Works Well for High-Risk TAVI Patients With HF: DapaTAVI Caitlin E. Cox March 30, 2025
Presentation ACC 2025 Dapagliflozin after Transcatheter Aortic Valve Implantation Presenter: Sergio Raposeiras-Roubin March 29, 2025
News Features What’s in a Name: Is It Time to Choose Between TAVI and TAVR? Yael L. Maxwell March 27, 2025
News Daily News ELASTA-Clip Plus TMVR Safe, Feasible for Failed M-TEER Caitlin E. Cox February 14, 2025